For pre-flush stage, hydrochloric acid and ammonium chloride were discussed in guidelines.
Bioassay design issues have been discussed in guidelines by the NTP (Melnick et al. 2008; NTP 2011a), in U.S. EPA pesticide program guidance (U.S. EPA 1998), and in U.S. Food and Drug Administration FDAA) "Redbook" guidelines (FDA 2000).
Because use of personal genetic information looks certain to directly impact our daily lives in the near future, protocols need to be discussed in detail, with guidelines provided and updated regularly as part of a regulated multidisciplinary approach.
All relevant aspects of this topic are going to be discussed in a new treatment guideline for medication-overuse headache, which is prepared by the DMKG, DGN, ÖKG and SKG within the next months.
Although the literature about guidelines mostly regards therapeutic interventions, (Davey et al. 2011) while our TDs focussed on diagnostic reasoning, 16.2 % of the words in our sample were spent on patient management, so we would have expected guidelines to be discussed in some TDs.
Where different from the ILCOR guidelines, issues will be discussed in the context of the latest evidence.
Our analysis was part of the evidence considered in developing the guidelines, as will be discussed in an upcoming evidence review, which will be made publicly available online by Vancouver Coastal Health.
The optimization guidelines of programming conditions will be discussed in detail in the following sections.
Epidemiology was discussed in all guidelines, etiology in all but the Italian leaflet for general practitioners.
When comparing the different versions of the German, the Dutch CBO and the ESC guideline, the emergence of new evidence for β-blockers and spironolactone is reflected by the order in which it is discussed in the guidelines: β-blockers in the old versions were the fourth or later topic, in the new versions they were moved to second or third.
